Review



virus forward primer reverse primer length bp rice dwarf virus cgatcccgggaat tcgga ccgaattcccggg atcc 525 rice stripe virus  (ATCC)


Bioz Verified Symbol ATCC is a verified supplier
Bioz Manufacturer Symbol ATCC manufactures this product  
  • Logo
  • About
  • News
  • Press Release
  • Team
  • Advisors
  • Partners
  • Contact
  • Bioz Stars
  • Bioz vStars
  • 94

    Structured Review

    ATCC virus forward primer reverse primer length bp rice dwarf virus cgatcccgggaat tcgga ccgaattcccggg atcc 525 rice stripe virus
    Virus Forward Primer Reverse Primer Length Bp Rice Dwarf Virus Cgatcccgggaat Tcgga Ccgaattcccggg Atcc 525 Rice Stripe Virus, supplied by ATCC, used in various techniques. Bioz Stars score: 94/100, based on 2 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/virus forward primer reverse primer length bp rice dwarf virus cgatcccgggaat tcgga ccgaattcccggg atcc 525 rice stripe virus/product/ATCC
    Average 94 stars, based on 2 article reviews
    virus forward primer reverse primer length bp rice dwarf virus cgatcccgggaat tcgga ccgaattcccggg atcc 525 rice stripe virus - by Bioz Stars, 2026-02
    94/100 stars

    Images



    Similar Products

    94
    ATCC virus forward primer reverse primer length bp rice dwarf virus cgatcccgggaat tcgga ccgaattcccggg atcc 525 rice stripe virus
    Virus Forward Primer Reverse Primer Length Bp Rice Dwarf Virus Cgatcccgggaat Tcgga Ccgaattcccggg Atcc 525 Rice Stripe Virus, supplied by ATCC, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/virus forward primer reverse primer length bp rice dwarf virus cgatcccgggaat tcgga ccgaattcccggg atcc 525 rice stripe virus/product/ATCC
    Average 94 stars, based on 1 article reviews
    virus forward primer reverse primer length bp rice dwarf virus cgatcccgggaat tcgga ccgaattcccggg atcc 525 rice stripe virus - by Bioz Stars, 2026-02
    94/100 stars
      Buy from Supplier

    99
    Hamilton Company custom 33g needle
    Custom 33g Needle, supplied by Hamilton Company, used in various techniques. Bioz Stars score: 99/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/custom 33g needle/product/Hamilton Company
    Average 99 stars, based on 1 article reviews
    custom 33g needle - by Bioz Stars, 2026-02
    99/100 stars
      Buy from Supplier

    96
    DeNovix length quantitation
    Length Quantitation, supplied by DeNovix, used in various techniques. Bioz Stars score: 96/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/length quantitation/product/DeNovix
    Average 96 stars, based on 1 article reviews
    length quantitation - by Bioz Stars, 2026-02
    96/100 stars
      Buy from Supplier

    97
    MedChemExpress lactate b2227
    ZCWPW2 shows enhanced enrichment at sites co-marked by H3K4me3 and H3K36me3 in the presence of PRDM9 and is found in complex with ZCWPW1 at these sites. ( A ) Schematic overview of CUT&Tag profiling of ZCWPW2 genomic binding sites in HEK293T cells transfected with Flag- ZCWPW2 (W2) alone or co-transfected with Myc- PRDM9 B . ( B ) Pie charts showing the genomic annotation of ZCWPW2 (W2) binding peaks in HEK293T cells transfected with Flag- ZCWPW2 alone (left) or co-transfected with Myc- PRDM9 B (right). ( C ) Bar graph showing the percentage of the top 10 000 ZCWPW2 (W2) or ZCWPW1 (W1) peaks overlapping with PRDM9-binding sites in the presence or absence of PRDM9. ( D ) Line plot showing ZCWPW2 (W2) binding signal centered around PRDM9 binding motifs (±3 kb) in HEK293T cells expressing Flag-ZCWPW2 with or without Myc-PRDM9. ( E ) Heatmaps and average signal plots showing ZCWPW2 (W2) enrichment centered on PRDM9-binding peaks (±2 kb) in HEK293T cells transfected with Flag- ZCWPW2 alone, co-transfected with Myc- PRDM9 B , or IgG control. ( F ) Venn diagram showing the overlap among ZCWPW2 (W2), ZCWPW1 (W1), and PRDM9 peaks in HEK293T cells co-expressing Myc-PRDM9. ( G ) Genome tracks snapshot showing representative genomic regions with binding profiles of ZCWPW2 (W2), ZCWPW1 (W1), and PRDM9 in HEK293T cells. ( H ) Genome track snapshots showing ZCWPW2 (W2) signals (green) in HEK293T cells co-expressing Flag-ZCWPW2 and Myc-PRDM9, and ZCWPW2 (W2) signals (blue) in cells expressing Flag-ZCWPW2 alone, together with tracks for PRDM9-induced H3K4me3 (pink) and H3K36me3 (orange). ( I ) ZCWPW2 peaks at H3K4me3/H3K36me3 sites in HEK293T cells co-expressing Flag-ZCWPW2 and Myc-PRDM9, as well as in cells expressing Flag-ZCWPW2 alone. ( J ) Co-IP assays were performed in HEK293T cells co-transfected with HA- ZCWPW1 (W1) and Flag- ZCWPW2 (W2). (K and L) Co-IP assays were performed on human ( K ) and mouse ( L ) testis lysates to detect endogenous interactions between ZCWPW1 (W1) and ZCWPW2 (W2). ( M ) Schematic overview <t>showing</t> <t>full-length</t> ZCWPW2 ( W2 ) and ZCWPW1( W1 ), along with their domain-deletion variants lacking either the zf-CW domain (ΔC), the PWWP domain (ΔP), or both (ΔC-ΔP), were generated and were co-transfected in HEK293T cells. ( N ) Co-IP analysis showing the interaction between full-length ZCWPW1 (W1) and full-length or domain-deletion variants of ZCWPW2 (W2). ( O ) Co-IP analysis of ZCWPW2 containing the PWWP domain (W2-ΔC) and full-length or domain-deletion variants of ZCWPW1 (W1) in HEK293T cells. Data for ZCWPW1 ChIP-seq in HEK293T cells, either transfected alone or co-transfected with PRDM9, were obtained from the GEO repository under accession number GSE141516 . ChIP-seq data for PRDM9 in HEK293T cells were retrieved from GEO accession GSE99407 .
    Lactate B2227, supplied by MedChemExpress, used in various techniques. Bioz Stars score: 97/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/lactate b2227/product/MedChemExpress
    Average 97 stars, based on 1 article reviews
    lactate b2227 - by Bioz Stars, 2026-02
    97/100 stars
      Buy from Supplier

    95
    Genecopoeia full length ddx3x mcherry construct
    A . Schematic representation of <t>DDX3X</t> protein showing pathogenic mutations identified in DDX3X syndrome patients (bold- multiple occurrences, blue- polymicrogyria, brown- male patients). B . Schematic representation of DDX3X functional domains indicating critical DDX3X syndrome-associated mutations selected based on their predicted structural impact. Blue, RNA binding sites; Red, ATP binding and hydrolysis regions; Magenta, regions of interaction between ATP binding and RNA binding residues. C . Ribbon structural representation of DDX3X (dark grey) bound to dsRNA (red) (PDB ID: 6O5F), displaying surface accessibility and RNA interface proximity of DDX3X syndrome mutations. Mutated residues are color-coded in the represented structure. D . Heat map depicting the AlphaMissense prediction for the likely pathogenicity of selected DDX3X syndrome missense mutations, with dark red being the likely pathogenic and white being the likely benign mutation. E . Table depicting selected mutations in DDX3X that have been associated with different cancer types. F . Immunoblotting analysis of DDX3X showing the impact of DDX3X syndrome mutations on protein expression in Neuro2a cells. G . Fluorescence images of N2a cells <t>expressing</t> <t>DDX3X-mCherry</t> with DDX3X syndrome mutations, captured using Incucyte imager.
    Full Length Ddx3x Mcherry Construct, supplied by Genecopoeia, used in various techniques. Bioz Stars score: 95/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/full length ddx3x mcherry construct/product/Genecopoeia
    Average 95 stars, based on 1 article reviews
    full length ddx3x mcherry construct - by Bioz Stars, 2026-02
    95/100 stars
      Buy from Supplier

    99
    Zymo Research full length 16s rrna gene amplification total genomic dna gdna
    A . Schematic representation of <t>DDX3X</t> protein showing pathogenic mutations identified in DDX3X syndrome patients (bold- multiple occurrences, blue- polymicrogyria, brown- male patients). B . Schematic representation of DDX3X functional domains indicating critical DDX3X syndrome-associated mutations selected based on their predicted structural impact. Blue, RNA binding sites; Red, ATP binding and hydrolysis regions; Magenta, regions of interaction between ATP binding and RNA binding residues. C . Ribbon structural representation of DDX3X (dark grey) bound to dsRNA (red) (PDB ID: 6O5F), displaying surface accessibility and RNA interface proximity of DDX3X syndrome mutations. Mutated residues are color-coded in the represented structure. D . Heat map depicting the AlphaMissense prediction for the likely pathogenicity of selected DDX3X syndrome missense mutations, with dark red being the likely pathogenic and white being the likely benign mutation. E . Table depicting selected mutations in DDX3X that have been associated with different cancer types. F . Immunoblotting analysis of DDX3X showing the impact of DDX3X syndrome mutations on protein expression in Neuro2a cells. G . Fluorescence images of N2a cells <t>expressing</t> <t>DDX3X-mCherry</t> with DDX3X syndrome mutations, captured using Incucyte imager.
    Full Length 16s Rrna Gene Amplification Total Genomic Dna Gdna, supplied by Zymo Research, used in various techniques. Bioz Stars score: 99/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/full length 16s rrna gene amplification total genomic dna gdna/product/Zymo Research
    Average 99 stars, based on 1 article reviews
    full length 16s rrna gene amplification total genomic dna gdna - by Bioz Stars, 2026-02
    99/100 stars
      Buy from Supplier

    90
    ATCC p re ss faecalibacterium 928tot node 264 length 102665 faecalibacterium apc918 95b cp030777 faecalibacterium apc923
    A . Schematic representation of <t>DDX3X</t> protein showing pathogenic mutations identified in DDX3X syndrome patients (bold- multiple occurrences, blue- polymicrogyria, brown- male patients). B . Schematic representation of DDX3X functional domains indicating critical DDX3X syndrome-associated mutations selected based on their predicted structural impact. Blue, RNA binding sites; Red, ATP binding and hydrolysis regions; Magenta, regions of interaction between ATP binding and RNA binding residues. C . Ribbon structural representation of DDX3X (dark grey) bound to dsRNA (red) (PDB ID: 6O5F), displaying surface accessibility and RNA interface proximity of DDX3X syndrome mutations. Mutated residues are color-coded in the represented structure. D . Heat map depicting the AlphaMissense prediction for the likely pathogenicity of selected DDX3X syndrome missense mutations, with dark red being the likely pathogenic and white being the likely benign mutation. E . Table depicting selected mutations in DDX3X that have been associated with different cancer types. F . Immunoblotting analysis of DDX3X showing the impact of DDX3X syndrome mutations on protein expression in Neuro2a cells. G . Fluorescence images of N2a cells <t>expressing</t> <t>DDX3X-mCherry</t> with DDX3X syndrome mutations, captured using Incucyte imager.
    P Re Ss Faecalibacterium 928tot Node 264 Length 102665 Faecalibacterium Apc918 95b Cp030777 Faecalibacterium Apc923, supplied by ATCC, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/p re ss faecalibacterium 928tot node 264 length 102665 faecalibacterium apc918 95b cp030777 faecalibacterium apc923/product/ATCC
    Average 90 stars, based on 1 article reviews
    p re ss faecalibacterium 928tot node 264 length 102665 faecalibacterium apc918 95b cp030777 faecalibacterium apc923 - by Bioz Stars, 2026-02
    90/100 stars
      Buy from Supplier

    94
    Sino Biological full length desmin protein
    A . Schematic representation of <t>DDX3X</t> protein showing pathogenic mutations identified in DDX3X syndrome patients (bold- multiple occurrences, blue- polymicrogyria, brown- male patients). B . Schematic representation of DDX3X functional domains indicating critical DDX3X syndrome-associated mutations selected based on their predicted structural impact. Blue, RNA binding sites; Red, ATP binding and hydrolysis regions; Magenta, regions of interaction between ATP binding and RNA binding residues. C . Ribbon structural representation of DDX3X (dark grey) bound to dsRNA (red) (PDB ID: 6O5F), displaying surface accessibility and RNA interface proximity of DDX3X syndrome mutations. Mutated residues are color-coded in the represented structure. D . Heat map depicting the AlphaMissense prediction for the likely pathogenicity of selected DDX3X syndrome missense mutations, with dark red being the likely pathogenic and white being the likely benign mutation. E . Table depicting selected mutations in DDX3X that have been associated with different cancer types. F . Immunoblotting analysis of DDX3X showing the impact of DDX3X syndrome mutations on protein expression in Neuro2a cells. G . Fluorescence images of N2a cells <t>expressing</t> <t>DDX3X-mCherry</t> with DDX3X syndrome mutations, captured using Incucyte imager.
    Full Length Desmin Protein, supplied by Sino Biological, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/full length desmin protein/product/Sino Biological
    Average 94 stars, based on 1 article reviews
    full length desmin protein - by Bioz Stars, 2026-02
    94/100 stars
      Buy from Supplier

    97
    TaKaRa rabbit antigfp
    A . Schematic representation of <t>DDX3X</t> protein showing pathogenic mutations identified in DDX3X syndrome patients (bold- multiple occurrences, blue- polymicrogyria, brown- male patients). B . Schematic representation of DDX3X functional domains indicating critical DDX3X syndrome-associated mutations selected based on their predicted structural impact. Blue, RNA binding sites; Red, ATP binding and hydrolysis regions; Magenta, regions of interaction between ATP binding and RNA binding residues. C . Ribbon structural representation of DDX3X (dark grey) bound to dsRNA (red) (PDB ID: 6O5F), displaying surface accessibility and RNA interface proximity of DDX3X syndrome mutations. Mutated residues are color-coded in the represented structure. D . Heat map depicting the AlphaMissense prediction for the likely pathogenicity of selected DDX3X syndrome missense mutations, with dark red being the likely pathogenic and white being the likely benign mutation. E . Table depicting selected mutations in DDX3X that have been associated with different cancer types. F . Immunoblotting analysis of DDX3X showing the impact of DDX3X syndrome mutations on protein expression in Neuro2a cells. G . Fluorescence images of N2a cells <t>expressing</t> <t>DDX3X-mCherry</t> with DDX3X syndrome mutations, captured using Incucyte imager.
    Rabbit Antigfp, supplied by TaKaRa, used in various techniques. Bioz Stars score: 97/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/rabbit antigfp/product/TaKaRa
    Average 97 stars, based on 1 article reviews
    rabbit antigfp - by Bioz Stars, 2026-02
    97/100 stars
      Buy from Supplier

    99
    Hamilton Company 33 gauge hamilton syringe
    A . Schematic representation of <t>DDX3X</t> protein showing pathogenic mutations identified in DDX3X syndrome patients (bold- multiple occurrences, blue- polymicrogyria, brown- male patients). B . Schematic representation of DDX3X functional domains indicating critical DDX3X syndrome-associated mutations selected based on their predicted structural impact. Blue, RNA binding sites; Red, ATP binding and hydrolysis regions; Magenta, regions of interaction between ATP binding and RNA binding residues. C . Ribbon structural representation of DDX3X (dark grey) bound to dsRNA (red) (PDB ID: 6O5F), displaying surface accessibility and RNA interface proximity of DDX3X syndrome mutations. Mutated residues are color-coded in the represented structure. D . Heat map depicting the AlphaMissense prediction for the likely pathogenicity of selected DDX3X syndrome missense mutations, with dark red being the likely pathogenic and white being the likely benign mutation. E . Table depicting selected mutations in DDX3X that have been associated with different cancer types. F . Immunoblotting analysis of DDX3X showing the impact of DDX3X syndrome mutations on protein expression in Neuro2a cells. G . Fluorescence images of N2a cells <t>expressing</t> <t>DDX3X-mCherry</t> with DDX3X syndrome mutations, captured using Incucyte imager.
    33 Gauge Hamilton Syringe, supplied by Hamilton Company, used in various techniques. Bioz Stars score: 99/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/33 gauge hamilton syringe/product/Hamilton Company
    Average 99 stars, based on 1 article reviews
    33 gauge hamilton syringe - by Bioz Stars, 2026-02
    99/100 stars
      Buy from Supplier

    Image Search Results


    ZCWPW2 shows enhanced enrichment at sites co-marked by H3K4me3 and H3K36me3 in the presence of PRDM9 and is found in complex with ZCWPW1 at these sites. ( A ) Schematic overview of CUT&Tag profiling of ZCWPW2 genomic binding sites in HEK293T cells transfected with Flag- ZCWPW2 (W2) alone or co-transfected with Myc- PRDM9 B . ( B ) Pie charts showing the genomic annotation of ZCWPW2 (W2) binding peaks in HEK293T cells transfected with Flag- ZCWPW2 alone (left) or co-transfected with Myc- PRDM9 B (right). ( C ) Bar graph showing the percentage of the top 10 000 ZCWPW2 (W2) or ZCWPW1 (W1) peaks overlapping with PRDM9-binding sites in the presence or absence of PRDM9. ( D ) Line plot showing ZCWPW2 (W2) binding signal centered around PRDM9 binding motifs (±3 kb) in HEK293T cells expressing Flag-ZCWPW2 with or without Myc-PRDM9. ( E ) Heatmaps and average signal plots showing ZCWPW2 (W2) enrichment centered on PRDM9-binding peaks (±2 kb) in HEK293T cells transfected with Flag- ZCWPW2 alone, co-transfected with Myc- PRDM9 B , or IgG control. ( F ) Venn diagram showing the overlap among ZCWPW2 (W2), ZCWPW1 (W1), and PRDM9 peaks in HEK293T cells co-expressing Myc-PRDM9. ( G ) Genome tracks snapshot showing representative genomic regions with binding profiles of ZCWPW2 (W2), ZCWPW1 (W1), and PRDM9 in HEK293T cells. ( H ) Genome track snapshots showing ZCWPW2 (W2) signals (green) in HEK293T cells co-expressing Flag-ZCWPW2 and Myc-PRDM9, and ZCWPW2 (W2) signals (blue) in cells expressing Flag-ZCWPW2 alone, together with tracks for PRDM9-induced H3K4me3 (pink) and H3K36me3 (orange). ( I ) ZCWPW2 peaks at H3K4me3/H3K36me3 sites in HEK293T cells co-expressing Flag-ZCWPW2 and Myc-PRDM9, as well as in cells expressing Flag-ZCWPW2 alone. ( J ) Co-IP assays were performed in HEK293T cells co-transfected with HA- ZCWPW1 (W1) and Flag- ZCWPW2 (W2). (K and L) Co-IP assays were performed on human ( K ) and mouse ( L ) testis lysates to detect endogenous interactions between ZCWPW1 (W1) and ZCWPW2 (W2). ( M ) Schematic overview showing full-length ZCWPW2 ( W2 ) and ZCWPW1( W1 ), along with their domain-deletion variants lacking either the zf-CW domain (ΔC), the PWWP domain (ΔP), or both (ΔC-ΔP), were generated and were co-transfected in HEK293T cells. ( N ) Co-IP analysis showing the interaction between full-length ZCWPW1 (W1) and full-length or domain-deletion variants of ZCWPW2 (W2). ( O ) Co-IP analysis of ZCWPW2 containing the PWWP domain (W2-ΔC) and full-length or domain-deletion variants of ZCWPW1 (W1) in HEK293T cells. Data for ZCWPW1 ChIP-seq in HEK293T cells, either transfected alone or co-transfected with PRDM9, were obtained from the GEO repository under accession number GSE141516 . ChIP-seq data for PRDM9 in HEK293T cells were retrieved from GEO accession GSE99407 .

    Journal: Nucleic Acids Research

    Article Title: A novel dual histone mark reader ZCWPW2 regulates meiotic recombination through lactylation and transcriptional regulation in humans and mice

    doi: 10.1093/nar/gkag049

    Figure Lengend Snippet: ZCWPW2 shows enhanced enrichment at sites co-marked by H3K4me3 and H3K36me3 in the presence of PRDM9 and is found in complex with ZCWPW1 at these sites. ( A ) Schematic overview of CUT&Tag profiling of ZCWPW2 genomic binding sites in HEK293T cells transfected with Flag- ZCWPW2 (W2) alone or co-transfected with Myc- PRDM9 B . ( B ) Pie charts showing the genomic annotation of ZCWPW2 (W2) binding peaks in HEK293T cells transfected with Flag- ZCWPW2 alone (left) or co-transfected with Myc- PRDM9 B (right). ( C ) Bar graph showing the percentage of the top 10 000 ZCWPW2 (W2) or ZCWPW1 (W1) peaks overlapping with PRDM9-binding sites in the presence or absence of PRDM9. ( D ) Line plot showing ZCWPW2 (W2) binding signal centered around PRDM9 binding motifs (±3 kb) in HEK293T cells expressing Flag-ZCWPW2 with or without Myc-PRDM9. ( E ) Heatmaps and average signal plots showing ZCWPW2 (W2) enrichment centered on PRDM9-binding peaks (±2 kb) in HEK293T cells transfected with Flag- ZCWPW2 alone, co-transfected with Myc- PRDM9 B , or IgG control. ( F ) Venn diagram showing the overlap among ZCWPW2 (W2), ZCWPW1 (W1), and PRDM9 peaks in HEK293T cells co-expressing Myc-PRDM9. ( G ) Genome tracks snapshot showing representative genomic regions with binding profiles of ZCWPW2 (W2), ZCWPW1 (W1), and PRDM9 in HEK293T cells. ( H ) Genome track snapshots showing ZCWPW2 (W2) signals (green) in HEK293T cells co-expressing Flag-ZCWPW2 and Myc-PRDM9, and ZCWPW2 (W2) signals (blue) in cells expressing Flag-ZCWPW2 alone, together with tracks for PRDM9-induced H3K4me3 (pink) and H3K36me3 (orange). ( I ) ZCWPW2 peaks at H3K4me3/H3K36me3 sites in HEK293T cells co-expressing Flag-ZCWPW2 and Myc-PRDM9, as well as in cells expressing Flag-ZCWPW2 alone. ( J ) Co-IP assays were performed in HEK293T cells co-transfected with HA- ZCWPW1 (W1) and Flag- ZCWPW2 (W2). (K and L) Co-IP assays were performed on human ( K ) and mouse ( L ) testis lysates to detect endogenous interactions between ZCWPW1 (W1) and ZCWPW2 (W2). ( M ) Schematic overview showing full-length ZCWPW2 ( W2 ) and ZCWPW1( W1 ), along with their domain-deletion variants lacking either the zf-CW domain (ΔC), the PWWP domain (ΔP), or both (ΔC-ΔP), were generated and were co-transfected in HEK293T cells. ( N ) Co-IP analysis showing the interaction between full-length ZCWPW1 (W1) and full-length or domain-deletion variants of ZCWPW2 (W2). ( O ) Co-IP analysis of ZCWPW2 containing the PWWP domain (W2-ΔC) and full-length or domain-deletion variants of ZCWPW1 (W1) in HEK293T cells. Data for ZCWPW1 ChIP-seq in HEK293T cells, either transfected alone or co-transfected with PRDM9, were obtained from the GEO repository under accession number GSE141516 . ChIP-seq data for PRDM9 in HEK293T cells were retrieved from GEO accession GSE99407 .

    Article Snippet: Cells were treated with 20 mM lactate (MedChemEpress, HY-B2227) for 14 h. Full-length cDNAs of ZCWPW1, ZCWPW2, PRDM9 B , SYCP1, HSPA2, SYCE1, SPATA22, TEX11, MLH1, MSH2, LDHA , or MDC1 were synthesized and cloned into pcDNATM3.1(+) vectors with Flag, HA, or Myc tags by the commercial biotechnology companies PAIVIBIO (China) and TSINGKE (China).

    Techniques: Binding Assay, Transfection, Expressing, Control, Co-Immunoprecipitation Assay, Generated, ChIP-sequencing

    A . Schematic representation of DDX3X protein showing pathogenic mutations identified in DDX3X syndrome patients (bold- multiple occurrences, blue- polymicrogyria, brown- male patients). B . Schematic representation of DDX3X functional domains indicating critical DDX3X syndrome-associated mutations selected based on their predicted structural impact. Blue, RNA binding sites; Red, ATP binding and hydrolysis regions; Magenta, regions of interaction between ATP binding and RNA binding residues. C . Ribbon structural representation of DDX3X (dark grey) bound to dsRNA (red) (PDB ID: 6O5F), displaying surface accessibility and RNA interface proximity of DDX3X syndrome mutations. Mutated residues are color-coded in the represented structure. D . Heat map depicting the AlphaMissense prediction for the likely pathogenicity of selected DDX3X syndrome missense mutations, with dark red being the likely pathogenic and white being the likely benign mutation. E . Table depicting selected mutations in DDX3X that have been associated with different cancer types. F . Immunoblotting analysis of DDX3X showing the impact of DDX3X syndrome mutations on protein expression in Neuro2a cells. G . Fluorescence images of N2a cells expressing DDX3X-mCherry with DDX3X syndrome mutations, captured using Incucyte imager.

    Journal: bioRxiv

    Article Title: DDX3X syndrome mutations lock DDX3X-RNA conformational states to drive persistent pathological condensation and neuronal death

    doi: 10.64898/2026.01.29.702492

    Figure Lengend Snippet: A . Schematic representation of DDX3X protein showing pathogenic mutations identified in DDX3X syndrome patients (bold- multiple occurrences, blue- polymicrogyria, brown- male patients). B . Schematic representation of DDX3X functional domains indicating critical DDX3X syndrome-associated mutations selected based on their predicted structural impact. Blue, RNA binding sites; Red, ATP binding and hydrolysis regions; Magenta, regions of interaction between ATP binding and RNA binding residues. C . Ribbon structural representation of DDX3X (dark grey) bound to dsRNA (red) (PDB ID: 6O5F), displaying surface accessibility and RNA interface proximity of DDX3X syndrome mutations. Mutated residues are color-coded in the represented structure. D . Heat map depicting the AlphaMissense prediction for the likely pathogenicity of selected DDX3X syndrome missense mutations, with dark red being the likely pathogenic and white being the likely benign mutation. E . Table depicting selected mutations in DDX3X that have been associated with different cancer types. F . Immunoblotting analysis of DDX3X showing the impact of DDX3X syndrome mutations on protein expression in Neuro2a cells. G . Fluorescence images of N2a cells expressing DDX3X-mCherry with DDX3X syndrome mutations, captured using Incucyte imager.

    Article Snippet: Full length DDX3X-mCherry construct (pReceiver-M56-DDX3X-mCherry ) was procured from GeneCopoeia.

    Techniques: Functional Assay, RNA Binding Assay, Binding Assay, Mutagenesis, Western Blot, Expressing, Fluorescence

    A . Immunoblot analysis showing levels of DDX3X protein in HeLa WT & Ddx3x -/- cells. B . Representative confocal microscopy images of HeLa cells expressing WT or mutant DDX3X-mCherry constructs and subjected to SA (200µM) stress and immunostained for stress granule marker G3BP1 (green) and DAPI (blue). Scale bar=10µm. C-E . Quantification of numbers of DDX3X (red), G3BP1 (green), and DDX3X-G3BP1 (yellow) granules per cell quantified from ≥50 cells across three independent experiments exhibiting DDX3X colocalising with stress granules in HeLa cells. ****p < 0.0001, ***p = 0.0008 (DDX3X granules/cell), **p = 0.0022 (WT vs I190S), **p = 0.0028 (WT vs T323I), **p = 0.0031 (WT vs L556S) (G3BP1 granules/cells), ****p < 0.0001, **p = 0.0034 (G3BP1-DDX3X colocalised granules/cells) (One-way ANOVA test). Data shown are mean ± SEM.

    Journal: bioRxiv

    Article Title: DDX3X syndrome mutations lock DDX3X-RNA conformational states to drive persistent pathological condensation and neuronal death

    doi: 10.64898/2026.01.29.702492

    Figure Lengend Snippet: A . Immunoblot analysis showing levels of DDX3X protein in HeLa WT & Ddx3x -/- cells. B . Representative confocal microscopy images of HeLa cells expressing WT or mutant DDX3X-mCherry constructs and subjected to SA (200µM) stress and immunostained for stress granule marker G3BP1 (green) and DAPI (blue). Scale bar=10µm. C-E . Quantification of numbers of DDX3X (red), G3BP1 (green), and DDX3X-G3BP1 (yellow) granules per cell quantified from ≥50 cells across three independent experiments exhibiting DDX3X colocalising with stress granules in HeLa cells. ****p < 0.0001, ***p = 0.0008 (DDX3X granules/cell), **p = 0.0022 (WT vs I190S), **p = 0.0028 (WT vs T323I), **p = 0.0031 (WT vs L556S) (G3BP1 granules/cells), ****p < 0.0001, **p = 0.0034 (G3BP1-DDX3X colocalised granules/cells) (One-way ANOVA test). Data shown are mean ± SEM.

    Article Snippet: Full length DDX3X-mCherry construct (pReceiver-M56-DDX3X-mCherry ) was procured from GeneCopoeia.

    Techniques: Western Blot, Confocal Microscopy, Expressing, Mutagenesis, Construct, Marker

    A. Representative confocal images of N2a cells expressing WT or mutant DDX3X-mCherry subjected to SA (100µM) stress for 2 hours and immunostained for stress granule marker G3BP1 (green) and DAPI (blue). Scale bar=10µm. B-D . Quantification of numbers of DDX3X (red), G3BP1 (green) and DDX3X-G3BP1 (yellow) granules per cell from ≥ 30cells across three independent experiments exhibiting DDX3X colocalising with stress granules in N2a cells. ****p < 0.0001, ***p = 0.0003, *p = 0.0181 (DDX3X granules/cell), ****p < 0.0001, ***p = 0.0001 (WT VS T198P), ***p = 0.0003 (WT vs L559H),**p = 0.0016 (G3BP1 granules/cells), ****p < 0.0001, ***p = 0.0001, **p = 0.0013 (WT vs I190S), **p = 0.0024 (WT vs L559H) (G3BP1-DDX3X colocalised granules/cells) (One-way ANOVA test). Data shown are mean ± SEM.

    Journal: bioRxiv

    Article Title: DDX3X syndrome mutations lock DDX3X-RNA conformational states to drive persistent pathological condensation and neuronal death

    doi: 10.64898/2026.01.29.702492

    Figure Lengend Snippet: A. Representative confocal images of N2a cells expressing WT or mutant DDX3X-mCherry subjected to SA (100µM) stress for 2 hours and immunostained for stress granule marker G3BP1 (green) and DAPI (blue). Scale bar=10µm. B-D . Quantification of numbers of DDX3X (red), G3BP1 (green) and DDX3X-G3BP1 (yellow) granules per cell from ≥ 30cells across three independent experiments exhibiting DDX3X colocalising with stress granules in N2a cells. ****p < 0.0001, ***p = 0.0003, *p = 0.0181 (DDX3X granules/cell), ****p < 0.0001, ***p = 0.0001 (WT VS T198P), ***p = 0.0003 (WT vs L559H),**p = 0.0016 (G3BP1 granules/cells), ****p < 0.0001, ***p = 0.0001, **p = 0.0013 (WT vs I190S), **p = 0.0024 (WT vs L559H) (G3BP1-DDX3X colocalised granules/cells) (One-way ANOVA test). Data shown are mean ± SEM.

    Article Snippet: Full length DDX3X-mCherry construct (pReceiver-M56-DDX3X-mCherry ) was procured from GeneCopoeia.

    Techniques: Expressing, Mutagenesis, Marker

    A . Schematic showing the protocol used for monitoring persistent granules in cells. Cells were treated with sodium arsenite (SA), followed by removing SA and supplementing fresh media (wash-off, recovery period) to monitor persistent granules. B . Representative confocal microscopy images of HeLa cells expressing WT or mutant DDX3X-mCherry showing stress granules (SGs) upon SA treatment and after wash-off (recovery), immunostained for G3BP1 (green) and DAPI (blue). Scale bar = 10µm. C-D . Quantification of the number of DDX3X (red) and DDX3X-G3BP1 (yellow) granules per cell from ≥ 30 cells across three independent experiments to monitor the formation of persistent DDX3X-SGs due to DDX3X syndrome mutations in HeLa cells. ****p < 0.0001, ***p = 0.0002, **p = 0.0073 (WT vs WT-WO), **p = 0.0046 (R475G vs R475G-WO), ns = not significant (DDX3X granules/cell), ****p < 0.0001, ***p = 0.0001, **p = 0.0096 (G3BP1-DDX3X granules/cell) (one-way ANOVA test). Data shown are mean ± SEM. E . Representative confocal microscopy images of N2a cells expressing WT or mutant DDX3X-mCherry showing SGs upon SA treatment and after wash-off (recovery), immunostained for G3BP1 (green) and DAPI (blue). Scale bar = 10µm. F-G . Quantification of the number of DDX3X (red) and DDX3X-G3BP1 (yellow) granules per cell from ≥ 50 cells across three independent experiments to monitor the formation of persistent DDX3X-SGs due to DDX3X syndrome mutations in N2a cells., ***p = 0.0006, **p = 0.0033 (WT vs WT-WO), **p = 0.0020 (F182V vs F182V-WO), ns = non-significant (DDX3X granules/cell), ****p < 0.0001, ***p = 0.0003 (G3BP1-DDX3X granules/cell) (One-way ANOVA test). Data shown are mean ± SEM.

    Journal: bioRxiv

    Article Title: DDX3X syndrome mutations lock DDX3X-RNA conformational states to drive persistent pathological condensation and neuronal death

    doi: 10.64898/2026.01.29.702492

    Figure Lengend Snippet: A . Schematic showing the protocol used for monitoring persistent granules in cells. Cells were treated with sodium arsenite (SA), followed by removing SA and supplementing fresh media (wash-off, recovery period) to monitor persistent granules. B . Representative confocal microscopy images of HeLa cells expressing WT or mutant DDX3X-mCherry showing stress granules (SGs) upon SA treatment and after wash-off (recovery), immunostained for G3BP1 (green) and DAPI (blue). Scale bar = 10µm. C-D . Quantification of the number of DDX3X (red) and DDX3X-G3BP1 (yellow) granules per cell from ≥ 30 cells across three independent experiments to monitor the formation of persistent DDX3X-SGs due to DDX3X syndrome mutations in HeLa cells. ****p < 0.0001, ***p = 0.0002, **p = 0.0073 (WT vs WT-WO), **p = 0.0046 (R475G vs R475G-WO), ns = not significant (DDX3X granules/cell), ****p < 0.0001, ***p = 0.0001, **p = 0.0096 (G3BP1-DDX3X granules/cell) (one-way ANOVA test). Data shown are mean ± SEM. E . Representative confocal microscopy images of N2a cells expressing WT or mutant DDX3X-mCherry showing SGs upon SA treatment and after wash-off (recovery), immunostained for G3BP1 (green) and DAPI (blue). Scale bar = 10µm. F-G . Quantification of the number of DDX3X (red) and DDX3X-G3BP1 (yellow) granules per cell from ≥ 50 cells across three independent experiments to monitor the formation of persistent DDX3X-SGs due to DDX3X syndrome mutations in N2a cells., ***p = 0.0006, **p = 0.0033 (WT vs WT-WO), **p = 0.0020 (F182V vs F182V-WO), ns = non-significant (DDX3X granules/cell), ****p < 0.0001, ***p = 0.0003 (G3BP1-DDX3X granules/cell) (One-way ANOVA test). Data shown are mean ± SEM.

    Article Snippet: Full length DDX3X-mCherry construct (pReceiver-M56-DDX3X-mCherry ) was procured from GeneCopoeia.

    Techniques: Confocal Microscopy, Expressing, Mutagenesis

    A . Real-time time-lapse confocal images of HeLa cells expressing WT or mutant DDX3X-mCherry and subjected to SA (200µM) stress for 2 hours. A single SG (indicated by white dashed circle, as the region of interest) was photobleached and fluorescence recovery was recorded over 180s using confocal microscopy. B . The relative fluorescence intensity of mCherry (tagged to DDX3X) in SGs in HeLa cells before and after photobleaching as a function of time. Curves are representative of four independent experiments. C. Real-time time-lapse confocal images of N2a cells expressing WT or mutant DDX3X-mCherry and subjected to SA (100µM) stress for 2 hours. A single SG (indicated by a dashed circle, as the ROI) was photobleached, and fluorescence recovery was recorded over 150s using confocal microscopy. D. The relative fluorescence intensity of mCherry (tagged to DDX3X) in SGs in N2a cells before and after photobleaching as a function of time. Curves are representative of five independent experiments.

    Journal: bioRxiv

    Article Title: DDX3X syndrome mutations lock DDX3X-RNA conformational states to drive persistent pathological condensation and neuronal death

    doi: 10.64898/2026.01.29.702492

    Figure Lengend Snippet: A . Real-time time-lapse confocal images of HeLa cells expressing WT or mutant DDX3X-mCherry and subjected to SA (200µM) stress for 2 hours. A single SG (indicated by white dashed circle, as the region of interest) was photobleached and fluorescence recovery was recorded over 180s using confocal microscopy. B . The relative fluorescence intensity of mCherry (tagged to DDX3X) in SGs in HeLa cells before and after photobleaching as a function of time. Curves are representative of four independent experiments. C. Real-time time-lapse confocal images of N2a cells expressing WT or mutant DDX3X-mCherry and subjected to SA (100µM) stress for 2 hours. A single SG (indicated by a dashed circle, as the ROI) was photobleached, and fluorescence recovery was recorded over 150s using confocal microscopy. D. The relative fluorescence intensity of mCherry (tagged to DDX3X) in SGs in N2a cells before and after photobleaching as a function of time. Curves are representative of five independent experiments.

    Article Snippet: Full length DDX3X-mCherry construct (pReceiver-M56-DDX3X-mCherry ) was procured from GeneCopoeia.

    Techniques: Expressing, Mutagenesis, Fluorescence, Confocal Microscopy

    A. Schematic of the assay protocol to assess the effect of persistent SGs on global translation and cell death. B. Representative polysome profiles (A260 absorbance) of DDX3X syndrome mutants expressing N2a cell extracts treated with SA (100uM) followed by wash-off and recovery in SA-free media, indicating sedimentation (through 10%-50% sucrose gradient) of 40S & 60S ribosomal subunits, 80S monosomes and polysomes (n=3). C. Quantification of DDX3X-dependent mRNAs in the polysome fractions plotted as relative log2-fold change ratio of translated/untranslated fraction using gene-specific primers normalised to GAPDH (internal control). ****p < 0.0001, ***p = 0.0007 (WT vs L559H, RPL36A gene), ***p = 0.0002 (WT vs L559H, RPL13 gene), **p = 0.0034 (WT vs I190S, EIF3I gene), **p = 0.0024 (WT vs L556S, STAT1 gene), **p = 0.0035 (WT vs I190S, TOPBP1 gene), **p = 0.0016 (WT vs L556S, TOPBP1), **p = 0.00365 (WT vs F182V, GNB2 gene), *p = 0.0347 (One-way ANOVA). Data shown are mean ± SEM. D. Real-time cell death analysis by Sytox green staining of N2a cells expressing WT or mutant DDX3X-mCherry constructs treated with SA **p = 0.0079, *p = 0.0432 (WT vs I190S), *p = 0.0306 (WT vs L559H) (two-way ANOVA test). Data shown are mean ± SEM. E. Real-time cell death analysis by Sytox green staining of N2a cells expressing WT or mutant DDX3X constructs treated with Aβ peptide with or without SA treatment and wash off. ****p < 0.0001, ***p = 0.0004, **p = 0.0068 (two-way ANOVA test). Data shown are mean ± SEM. F. Cell death measurement by Sytox green staining of N2a cells expressing WT or mutant DDX3X treated with SA, followed by TNF and zVAD treatment. ****p < 0.0001, **p = 0.0020 (WT vs T198P), **p = 0.0038 (WT vs R480G), **p = 0.0053 (WT vs L556S), *p = 0.0182 (two-way ANOVA test). Data shown are mean ± SEM.

    Journal: bioRxiv

    Article Title: DDX3X syndrome mutations lock DDX3X-RNA conformational states to drive persistent pathological condensation and neuronal death

    doi: 10.64898/2026.01.29.702492

    Figure Lengend Snippet: A. Schematic of the assay protocol to assess the effect of persistent SGs on global translation and cell death. B. Representative polysome profiles (A260 absorbance) of DDX3X syndrome mutants expressing N2a cell extracts treated with SA (100uM) followed by wash-off and recovery in SA-free media, indicating sedimentation (through 10%-50% sucrose gradient) of 40S & 60S ribosomal subunits, 80S monosomes and polysomes (n=3). C. Quantification of DDX3X-dependent mRNAs in the polysome fractions plotted as relative log2-fold change ratio of translated/untranslated fraction using gene-specific primers normalised to GAPDH (internal control). ****p < 0.0001, ***p = 0.0007 (WT vs L559H, RPL36A gene), ***p = 0.0002 (WT vs L559H, RPL13 gene), **p = 0.0034 (WT vs I190S, EIF3I gene), **p = 0.0024 (WT vs L556S, STAT1 gene), **p = 0.0035 (WT vs I190S, TOPBP1 gene), **p = 0.0016 (WT vs L556S, TOPBP1), **p = 0.00365 (WT vs F182V, GNB2 gene), *p = 0.0347 (One-way ANOVA). Data shown are mean ± SEM. D. Real-time cell death analysis by Sytox green staining of N2a cells expressing WT or mutant DDX3X-mCherry constructs treated with SA **p = 0.0079, *p = 0.0432 (WT vs I190S), *p = 0.0306 (WT vs L559H) (two-way ANOVA test). Data shown are mean ± SEM. E. Real-time cell death analysis by Sytox green staining of N2a cells expressing WT or mutant DDX3X constructs treated with Aβ peptide with or without SA treatment and wash off. ****p < 0.0001, ***p = 0.0004, **p = 0.0068 (two-way ANOVA test). Data shown are mean ± SEM. F. Cell death measurement by Sytox green staining of N2a cells expressing WT or mutant DDX3X treated with SA, followed by TNF and zVAD treatment. ****p < 0.0001, **p = 0.0020 (WT vs T198P), **p = 0.0038 (WT vs R480G), **p = 0.0053 (WT vs L556S), *p = 0.0182 (two-way ANOVA test). Data shown are mean ± SEM.

    Article Snippet: Full length DDX3X-mCherry construct (pReceiver-M56-DDX3X-mCherry ) was procured from GeneCopoeia.

    Techniques: Expressing, Sedimentation, Control, Staining, Mutagenesis, Construct

    A. Cell death measurement by Sytox green staining of N2a cells ectopically expressing WT or mutant DDX3X-mCherry. ns = non-significant (Two-way ANOVA test). Data shown are mean ± SEM. B. Cell death measurement by Sytox green staining of N2a cells ectopically expressing WT or mutant DDX3X-mCherry treated with TNF and zVAD. Ns = non-significant, (Two-way ANOVA test). Data shown are mean ± SEM.

    Journal: bioRxiv

    Article Title: DDX3X syndrome mutations lock DDX3X-RNA conformational states to drive persistent pathological condensation and neuronal death

    doi: 10.64898/2026.01.29.702492

    Figure Lengend Snippet: A. Cell death measurement by Sytox green staining of N2a cells ectopically expressing WT or mutant DDX3X-mCherry. ns = non-significant (Two-way ANOVA test). Data shown are mean ± SEM. B. Cell death measurement by Sytox green staining of N2a cells ectopically expressing WT or mutant DDX3X-mCherry treated with TNF and zVAD. Ns = non-significant, (Two-way ANOVA test). Data shown are mean ± SEM.

    Article Snippet: Full length DDX3X-mCherry construct (pReceiver-M56-DDX3X-mCherry ) was procured from GeneCopoeia.

    Techniques: Staining, Expressing, Mutagenesis

    A . Schematic showing the protocol used for the cross-seeding kinetics of Aβ 1-42 aggregation by DDX3X seeds. B . Boltzmann fitting of the cross-seeding experiment depicting the co-aggregation kinetics of Aβ 1-42 when cross-seeded with sonicated seeds of DDX3X variants. C . Representative confocal images of N2a cells expressing WT or mutant DDX3X-mCherry, subjected to SA stress (100µM), wash-off, and recovery, followed by ThT staining and immunostained with DAPI (blue). ThT fluorescence is represented in green. Scale bar= 10µm. D-F . Quantification of numbers of DDX3X (red), ThT stained (green) and ThT-DDX3X (yellow) granules per cell from ≥ 20 cells across three independent experiments exhibiting DDX3X colocalization with ThT granules in N2a cells. ****p < 0.0001 (DDX3X granules/cell), ****p < 0.0001, ***p = 0.0005, **p = 0.0022 (WT vs I190S), **p = 0.0080 (WT vs T198P) (ThT granules/cells) ****p < 0.0001, ***p = 0.0003, **p = 0.0021 (WT vs I190S), **p = 0.0057 (WT vs T198P) (ThT-DDX3X colocalised granules/cells) (One-way ANOVA test). Data shown are mean ± SEM.

    Journal: bioRxiv

    Article Title: DDX3X syndrome mutations lock DDX3X-RNA conformational states to drive persistent pathological condensation and neuronal death

    doi: 10.64898/2026.01.29.702492

    Figure Lengend Snippet: A . Schematic showing the protocol used for the cross-seeding kinetics of Aβ 1-42 aggregation by DDX3X seeds. B . Boltzmann fitting of the cross-seeding experiment depicting the co-aggregation kinetics of Aβ 1-42 when cross-seeded with sonicated seeds of DDX3X variants. C . Representative confocal images of N2a cells expressing WT or mutant DDX3X-mCherry, subjected to SA stress (100µM), wash-off, and recovery, followed by ThT staining and immunostained with DAPI (blue). ThT fluorescence is represented in green. Scale bar= 10µm. D-F . Quantification of numbers of DDX3X (red), ThT stained (green) and ThT-DDX3X (yellow) granules per cell from ≥ 20 cells across three independent experiments exhibiting DDX3X colocalization with ThT granules in N2a cells. ****p < 0.0001 (DDX3X granules/cell), ****p < 0.0001, ***p = 0.0005, **p = 0.0022 (WT vs I190S), **p = 0.0080 (WT vs T198P) (ThT granules/cells) ****p < 0.0001, ***p = 0.0003, **p = 0.0021 (WT vs I190S), **p = 0.0057 (WT vs T198P) (ThT-DDX3X colocalised granules/cells) (One-way ANOVA test). Data shown are mean ± SEM.

    Article Snippet: Full length DDX3X-mCherry construct (pReceiver-M56-DDX3X-mCherry ) was procured from GeneCopoeia.

    Techniques: Sonication, Expressing, Mutagenesis, Staining, Fluorescence